CMR Surgical, a pioneering British medical device company headquartered in Cambridge, is at the forefront of advancing surgical care through robotic technology. The company's commitment to delivering the highest quality of care has led them to explore innovative solutions for minimal access surgery (MAS) using robotics.

At the heart of CMR Surgical's vision is the belief that robotics can play a pivotal role in extending the reach of minimal access surgery, making it accessible to a wider population. Their flagship creation, the Versius Surgical Robotic System, is designed with the intent to empower surgeons and redefine surgical procedures on a global scale.

CMR Surgical focuses on collaboration rather than mere sales. By partnering with surgical teams and hospitals, the company ensures that the transformative benefits of MAS are fully realized by patients, healthcare professionals, and medical institutions alike.

CMR's journey began in 2014 when CMR Surgical's founders posed critical questions about the limited accessibility to minimal access surgery. These questions ignited a mission to bridge the gap, leading the company to its present status as a significant player in the medical technology sector, with a presence extending from the United Kingdom to various corners of the world.

The Versius Surgical Robotic System, CMR Surgical's flagship creation, stands as a testament to their commitment. This system, a competitor to established technologies like the da Vinci Surgical System, boasts a distinctive advantage with its modular arms that offer unparalleled flexibility and swift setup.

In practical terms, Versius has been successfully integrated into routine clinical practice across different continents. Renowned medical institutions such as Guy’s and St Thomas' (London), Royal Papworth (Cambridge), and several others in the UK, along with global locations such as Macquarie University Hospital in Australia, have embraced the system for its transformative capabilities in performing surgeries with reduced invasiveness and enhanced precision.

CMR Surgical's journey has been marked by significant milestones. Notably, in 2021, the company secured a $600 million investment during a series D financing round. The Versius robotic system has continually evolved, finding application in diverse surgical fields such as urology and thoracic procedures, and garnering recognition for its innovation.

CMR Surgical's journey exemplifies the fusion of cutting-edge technology, medical expertise, and a commitment to bettering patient outcomes. As they continue to push the boundaries of surgical robotics, CMR Surgical remains steadfast in their mission to empower surgeons and revolutionize the landscape of modern surgery.

Source: CMR Surgical